PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.89
ESG score 80-90% of ADAP's 71.95. Walter Schloss would scrutinize governance quality and regulatory exposure.
56.89
Environmental score 80-90% of ADAP's 70.34. Walter Schloss would scrutinize carbon exposure and transition planning.
57.56
Social score below 80% of ADAP's 72.40. Jim Chanos would check for potential social license and litigation risks.
59.23
Governance score 80-90% of ADAP's 73.10. Walter Schloss would scrutinize management accountability and board independence.